This is a working overview of 有关物质, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-03. Anything still debated is marked as such rather than presented as settled.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Approximate composition of the free peptide |
| Molecular weight | Approximately 4813 Da | Calculated for the free base |
| Structural class | Synthetic linear peptide | 39 residues with modified backbone |
| Solubility | Soluble in water and polar solvents | Behavior of the lyophilized solid |
| Typical storage temperature | -20 degrees Celsius or below | Solid form, protected from light |
定量分析的主流方法是反相高效液相色谱联用紫外或质谱检测，利用肽在疏水固定相上的保留行为确定纯度与含量。对于生物基质中的浓度测定，常采用液相色谱串联质谱，并配合固相萃取或蛋白沉淀进行样品前处理。免疫分析法也可使用，但可能受到结构相关肽的交叉反应干扰。
纯度评估通常综合反相色谱、体积排阻色谱与质谱三方面信息：前者反映疏水性杂质，后者反映聚集体，质谱则确认分子量与主要降解产物。有关降解途径的完整图谱——例如脱酰胺、氧化与水解各占多大比例——在不同储存条件下仍有差异，属于需要逐案验证的问题。
质量控制环节关注外观、含量、纯度、有关物质、水分与微生物限度等项目。检测结果需要有对照品和系统适用性数据支持，单次测定不足以判定批次的稳定性。实验室之间方法转移时，色谱柱品牌与梯度差异常导致保留时间漂移，因此方法验证十分必要。
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
Tirzepatide is a synthetic peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual agonist profile distinguishes it from earlier incretin-based compounds that act on a single receptor. The molecule was engineered from the native GIP sequence and carries several non-natural residues that slow enzymatic breakdown. Researchers designed it to combine the insulinotropic effects of GIP signaling with the appetite and gastric-emptying effects associated with GLP-1 activation.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Filter papers are widely used in laboratory experiments across many different fields, from biology to chemistry. The type of filter used will differ according to the purpose of the procedure and the chemicals involved. Generally, filter papers are used with laboratory techniques such as gravity or vacuum filtration. Historically, a type of soft, porous paper called charta emporetica was used in pharmacy as a filter and as packing paper.
In the African-American slave community, slaves quickly adopted funeral procedures and the location of gravesites of family and friends. Specific slaves were assigned to prepare dead bodies, build coffins, dig graves, and construct headstones. Slave funerals were typically at night when the workday was over, with the master present to view all the ceremonial procedures. Slaves from nearby plantations were regularly in attendance. At death, a slave's body was wrapped in cloth. The hands were placed across the chest, and a metal plate was placed on top of their hands. The reasoning for the plate was to hinder their return home by suppressing any spirits in the coffin. Often, personal property was buried with slaves to appease spirits. The coffins were nailed shut once the body was inside, and carried by hand or wagon, depending on the property designated for the slave burial site. Slaves were buried oriented east to west, with feet at the eastern end and head at the western end and the person thus rising facing east. According to Christian doctrine, this orientation permitted rising to face the return of Christ without having to turn around upon the call of Gabriel's trumpet. Gabriel's trumpet would be blown near the eastern sunrise.
== Prognosis == The progression to type 2 diabetes mellitus is not inevitable for those with prediabetes. The progression into diabetes mellitus from prediabetes is approximately 25% over three to five years. This increases to 50% risk of progressing to diabetes over 10 years. Diabetes is a leading cause of morbidity and mortality. Effects of the disease may affect larger blood vessels (e.g., atherosclerosis within the larger arteries of the cardiovascular system) or smaller blood vessels, as seen with damage to the retina of the eye, damage to the kidney, and damage to the nerves. Prediabetes is a risk factor for mortality and there is evidence of cardiovascular disease developing prior to a diagnosis of diabetes.
== L == Langerhans cells – LAS – lentivirus – lesion – leukocytes – leukocytosis – leukopenia – leukoplakia – LFT – LIP – lipid – lipodystrophy – liposomes – live vector vaccine – liver function test (LFT) – long terminal repeat sequence (LTR) – long-term nonprogressors – LTR – lumbar – lumbar puncture – lymph – lymph nodes – lymphadenopathy syndrome (LAS) – lymphatic vessels – lymphocyte – lymphoid interstitial pneumonitis (LIP) – lymphoid organs – lymphoid tissue – lymphokine-activated killer cells (LAK) – lymphokines – lymphoma – lymphopenia – lymphoproliferative response – lysis
Sources: en.wikipedia.org
The Dynamin-related protein 2b/drp2b gene in A. thaliana is not directly an immunity gene, but by helping move external material into the intracellular network is indirectly related, and some mutants increase susceptibility.
The same month, she collaborated with Trainline and attended King's Cross Station to promote their "Slaystation" service, a pop-up experience where commuters were able to get their hair and make-up done. In July 2025, Collins appeared in an online advertisement campaign for Sky Mobile, for which she fronted a satire video apologising about accidentally "oversharing" details about her wedding, before revealing she was "not sorry" and subsequently endorsed them for allowing users of the network to share their mobile data. As part of the partnership, Collins said "Oversharing is caring huns, don't stress about it – I've overshared all my life and I love it. Now with Sky Mobile, we can share even more – by gifting data so that those you love can keep the group chats going strong!" In October 2025, Collins starred in an advertisement for the gambling company Paddy Power alongside Danny Dyer and Coleen Rooney, in which Collins makes her way through a casino calling after Dyer, referencing her famous meme exclaiming "I'm claustrophobic Danny" before telling Rooney to "have a day off hun". In November 2025, Collins collaborated with the online retail service AliExpress as part of their "See the Signs 11.11" campaign, which saw her attend a pop-up event in Soho where she partook in a live stream and assisted with the promotion of their products, as well as selecting a random winner to receive a giant Labubu. In February 2026, Collins collaborated with the proprietary software company Canva.
In November 2011, the results of a double-blind, placebo-controlled study (financed by Hythiam and carried out at UCLA) were published in the peer-reviewed journal Addiction. It concluded that Gabasync is ineffective: "The PROMETA protocol, consisting of flumazenil, gabapentin, and hydroxyzine, appears to be no more effective than placebo in reducing methamphetamine use, retaining patients in treatment, or reducing methamphetamine craving."
==== Fiscal instability ==== The tax cuts included in the bill are predicted to greatly increase the federal debt in proportion to the GDP of the U.S. economy. Among other destabilizing effects, this may increase the cost of government borrowing as bond buyers demand a higher interest rate on new debt. Moody's, which rates bonds, was the final of the three credit rating agencies to downgrade U.S. debt from AAA, citing efforts to pass the bill. On June 28, the Committee for a Responsible Federal Budget (CRFB) said of the Senate version of the bill:
=== Alleged censorship of criticism of Donald Trump and Jeffrey Epstein === In 2026 TikTok was criticized for allegedly censoring criticism of Donald Trump and references to Jeffrey Epstein, with whom Trump had a long-standing relationship. California governor Gavin Newsom said the Government of California was launching an investigation of TikTok for violating California law by censoring Trump-critical content. TikTok claimed it was not deliberately censoring content and blamed alleged power outages.
Sources: en.wikipedia.org
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.
Single-receptor agents act predominantly at GLP-1R. Tirzepatide retains activity at GIPR, which is expressed in pancreatic islets, adipose tissue, and the central nervous system. The contribution of each receptor to the overall response is still an area of active study, and the relative weight of GIPR signaling in humans is not fully settled.
The fatty diacid moiety binds serum albumin, which reduces renal filtration of the active peptide. Additional resistance to enzymatic breakdown comes from non-natural residues in the backbone. Together these features produce an apparent half-life of about five days and permit weekly dosing intervals.
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.